MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

    B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)

    Objective: Assess the feasibility of detecting brain iron deposition using quantitative susceptibility mapping (QSM) among patients with Parkinson’s disease (PD) in a community-based clinic setting.…
  • 2023 International Congress

    Muscle functions on the movement timings and inhibition in Parkinson’s disease.

    H. Singh, K S. Anand (Mysore, India)

    Objective: To assess the role of muscle strength, muscle tone and reflexes on the movement timings and inhibitory control in the subjects of Parkinson’s disease…
  • 2023 International Congress

    Comparative Analysis of Stepwise Unilateral and Simultaneous Bilateral Deep Brain Stimulator Electrode Placement for Parkinosn’s Disease

    K. Yekuno, M. Marsans, C. Drolet, J. Roberts, S. Srivastal, F. Farrokhi (Seattle, USA)

    Objective: The goal of this paper is to compare the time required to achieve the maximum possible quality of life (i.e. number of programming visits),…
  • 2023 International Congress

    Prevalence of cardiovascular drugs and oral anticoagulants use among persons with and without Parkinson’s disease

    B. Babar (Kuopio, Finland)

    Objective: We investigated prevalence of Cardiovascular drugs and Oral anticoagulants (OAC) use among community-dwelling persons with and without Parkinson's disease (PD) in relation to PD…
  • 2023 International Congress

    Age-associated changes in the striatal proteins in aging Asian-Indians

    H J. Jyothi, A. Mahadevan, T C. Yasha, P. Alladi (Bengaluru, India)

    Objective: To examine the age-related changes in tyrosine hydroxylase (TH), vesicular monoamine transporter2 (VMAT2), post-synaptic density protein-95 (PSD-95) and dopamine receptors (D1R, D2R) expression in the…
  • 2023 International Congress

    Questionnaire for the detection of Parkinson’s disease

    S. Abdraimova, R. Kaiyrzhanov, N. Zharkinbekova (Shymkent, Kazakhstan)

    Objective: The aim of this study was to develop a questionnaire for detecting Parkinson's disease in its early stages and to evaluate its effectiveness. Background:…
  • 2023 International Congress

    Marked reduction of energy supply due to levodopa treatment in patients with Parkinson’s disease and healthy controls

    J. Prasuhn, T. Schiefen, T. Grüber, J. Hekel, J. Uter, J. Steinhardt, B. Wilms, N. Brüggemann (Lübeck, Germany)

    Objective: To investigate the influence of a standardized, placebo-controlled administration of levodopa on cerebral bioenergetics in patients with Parkinson’s disease (PwPD) and healthy controls (HCs).…
  • 2023 International Congress

    Proteomic profiles analysis of plasma exosomes and WBC reveals news insights of PD patients classified into H&Y clinical stage

    BL. Fadel, N. Woldmar, G. Poralla, J. Fontes, L. Giacomin, M. Figueiredo, J. Evaristo, F. Nogueira, C. Panis, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

    Objective: To perform a comparative proteomic analysis of WBC and exosomes in samples from PD patients and to compare with healthy controls (HC) using a…
  • 2023 International Congress

    On-demand therapy (ODT) in Parkinson’s disease: a survey of advanced practice providers

    K. Papesh, A. Merriam, C. Zebendon (Phoenix, USA)

    Objective: A survey of neurology Advanced Practice Providers (APPs) provides insights into their perspectives on managing and treating patients with Parkinson’s disease (PD) in the…
  • 2023 International Congress

    An SNCA triplication in a Kazakhstani patient with young-onset Parkinson’s disease

    R. Kaiyrzhanov, C. Shashkin, N. Zharkinbekova, V. Akhmetzhanov, Z. Myrzayev, A. Karimova, S. Aidarov, K. Mok, H. Houlden (Shymkent, Kazakhstan)

    Objective: To report a patient with Parkinson’s disease (PD) from Kazakhstan with a rare structural defect in the SNCA gene. Background: Little is known about…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley